<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v3.0 20080202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing3.dtd?><?SourceDTD.Version 3.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Iran J Public Health</journal-id><journal-id journal-id-type="iso-abbrev">Iran. J. Public Health</journal-id><journal-id journal-id-type="publisher-id">IJPH</journal-id><journal-id journal-id-type="pmc">IJPH</journal-id><journal-title-group><journal-title>Iranian Journal of Public Health</journal-title></journal-title-group><issn pub-type="ppub">2251-6085</issn><issn pub-type="epub">2251-6093</issn><publisher><publisher-name>Tehran University of Medical Sciences</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6174061</article-id><article-id pub-id-type="publisher-id">ijph-47-1430</article-id><article-categories><subj-group subj-group-type="heading"><subject>Letter to the Editor</subject></subj-group></article-categories><title-group><article-title>Emergency Department Response in Dealing with Crimean-Congo Hemorrhagic Fever Patients</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>HAMZEH POUR</surname><given-names>Siavash</given-names></name><xref ref-type="aff" rid="AFF1"><sup>1</sup></xref><xref ref-type="corresp" rid="C1"><sup>*</sup></xref></contrib><contrib contrib-type="author"><name><surname>NAJAFI</surname><given-names>Maryam</given-names></name><xref ref-type="aff" rid="AFF2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>DANAEI KOIK</surname><given-names>Nima</given-names></name><xref ref-type="aff" rid="AFF3"><sup>3</sup></xref></contrib><aff id="AFF1"><label>1.</label> Dept. of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</aff><aff id="AFF2"><label>2.</label> Trauma Research Center, Kashan University of Medical Sciences, Kashan, Iran</aff><aff id="AFF3"><label>3.</label> Dept. of Medical Entomology and Vector Control, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</aff></contrib-group><author-notes><corresp id="C1"><label>*</label><bold>Corresponding Author:</bold> Email: <email>hseavash@yahoo.com</email></corresp></author-notes><pub-date pub-type="ppub"><month>9</month><year>2018</year></pub-date><volume>47</volume><issue>9</issue><fpage>1430</fpage><lpage>1431</lpage><history><date date-type="received"><day>21</day><month>11</month><year>2017</year></date><date date-type="accepted"><day>13</day><month>12</month><year>2017</year></date></history><permissions><copyright-statement>Copyright&#x000a9; Iranian Public Health Association &#x00026; Tehran University of Medical Sciences</copyright-statement><copyright-year>2018</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions></article-meta></front><body><sec><title>Dear Editor-in-Chief</title><p>Crimean-Congo hemorrhagic fever (CCHF) is a febrile hemorrhagic acute disease between animals and humans (Zoonoses), first reported in the Crimea, Ukraine, in 1944 and then in the Congo in 1954. Since then, the name of Crimean-Congo has been used for the virus (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B2" ref-type="bibr">2</xref>). CCHF is endemic and outbreaks have been recorded in many countries in Africa, the Middle East, Eastern Europe and Asia (<xref rid="B3" ref-type="bibr">3</xref>). The Crimean-Congo hemorrhagic fever virus (CCHFV) causes disease and belongs to the genus <italic>Nairovirus</italic> from the family Bunyaviridae. The genome of this virus is a single-stranded RNA virus with a negative polarity (<xref rid="B4" ref-type="bibr">4</xref>).</p><p>The CCHF disease can be transmitted via the bite of an infective adult tick, particularly <italic>Hyalomma marginatum</italic> or <italic>H. anatolicum</italic> and it can also be transmitted from infected animals and humans (<xref rid="B4" ref-type="bibr">4</xref>).</p><p>The disease was accompanied by a mild fever in animals, improved by itself after a short fever, but the incubation period in humans is dependent on the mode of transmission. As the incubation period in transmission via bites of infected ticks lasts between 1&#x02013;3 days and this period in transmission through the blood and tissues takes 6&#x02013;12 days.</p><p>Clinical manifestations of the disease include two stages: non-hemorrhagic and hemorrhagic stages. In the non-hemorrhagic stage, early symptoms of the disease including sudden onset of fever, weakness, severe pain in extremities, back pain, headache, anorexia, and photophobia were observed. In the hemorrhagic and bleeding stage, the symptoms, including bleeding from the gums, nose, leg and hand skin, lung, stomach, and intestine, usually appear four days after the onset of the disease. Severe leukopenia and thrombocytopenia can be seen particularly at this stage. The majority of the patients die from the shock, anemia, excessive bleeding and disseminated intravascular coagulation (DIC). The mortality rate of the disease is usually between 2% and 50% and the disease epidemic in hospital is more common, usually spread by contact with infected blood and body fluids or contaminated needles pushed through the skin (<xref rid="B5" ref-type="bibr">5</xref>&#x02013;<xref rid="B7" ref-type="bibr">7</xref>).</p><p>Rapid detection of the disease is necessary for monitoring and early treatment of the patients with specific antivirals such as ribavirin and supportive measures, preventing hospital epidemics and bioterrorism attacks of the CCHF virus. To identify the suspected cases of CCHF, biosafety level 4 (BSL4) laboratories are needed. Because in these laboratories specific IgM and IgG antibodies of the patients can be detected using the serological tests such as the ELISA method and also the isolation and sequencing of the genome can be tested by the reverse transcriptase-polymerase chain reaction (RT-PCR) (<xref rid="B7" ref-type="bibr">7</xref>,<xref rid="B8" ref-type="bibr">8</xref>).</p><p>Emergency personnel according to the emergency first aid priorities and before the official confirmation by the Arbovirus Laboratory of the Pasteur Institute and the Center for Infectious Diseases, Ministry of Health and Medical Education may attempt to treat patients without observing protective measures when dealing with the patients with the CCHF virus. Although the knowledge and awareness of the majority of physicians and nurses from the nature of the disease, modes of transmission and symptoms of the disease are relatively high, their knowledge is weak about the system of patient care, treatment of confirmed and suspected cases, as well as reporting of the cases of the disease.</p><p>Some cases of this virus and hospital outbreaks were reported in our country and there is no certain vaccine for this disease, necessary protective measures, including wearing gloves, gowns, head coverings, shoe covers, face covers, mask N95, surgical mask and protective glasses should be observed when dealing with persons suspected of having the CCHF disease. Also, transport of infectious specimens from suspected cases of the virus should be performed according to the particular protocol associated with the transport of high-risk infectious specimens (<xref rid="B9" ref-type="bibr">9</xref>, <xref rid="B10" ref-type="bibr">10</xref>).</p></sec></body><back><fn-group><fn fn-type="COI-statement"><p><bold>Conflict of interest</bold></p><p>The authors declare that there is no conflict of interests.</p></fn></fn-group><ref-list><title>References</title><ref id="B1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leblebicioglu</surname><given-names>H</given-names></name><name><surname>Ozaras</surname><given-names>R</given-names></name><name><surname>Irmak</surname><given-names>H</given-names></name><name><surname>Sencan</surname><given-names>I</given-names></name></person-group> (<year>2016</year>). <article-title>Crimean-Congo hemorrhagic fever in Turkey: Current status and future challenges</article-title>. <source>Antiviral Res</source>, <volume>126</volume>(<issue>2</issue>):<fpage>21</fpage>&#x02013;<lpage>34</lpage>.<pub-id pub-id-type="pmid">26695860</pub-id></mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whitehouse</surname><given-names>CA</given-names></name></person-group> (<year>2004</year>). <article-title>Crimean-Congo hemorrhagic fever</article-title>. <source>Antiviral Res</source>, <volume>64</volume> (<issue>3</issue>): <fpage>145</fpage>&#x02013;<lpage>160</lpage>.<pub-id pub-id-type="pmid">15550268</pub-id></mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dowall</surname><given-names>SD</given-names></name><name><surname>Buttigieg</surname><given-names>KR</given-names></name><name><surname>Findlay-Wilson</surname><given-names>SJD</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>A Crimean-Congo hemorrhagic fever (CCHF) viral vaccine expressing nucleoprotein is immunogenic but fails to confer protection against lethal disease</article-title>. <source>Hum Vaccin Immunother</source>, <volume>12</volume>(<issue>2</issue>): <fpage>519</fpage>&#x02013;<lpage>527</lpage>.<pub-id pub-id-type="pmid">26309231</pub-id></mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zivcec</surname><given-names>M</given-names></name><name><surname>Scholte</surname><given-names>EM F</given-names></name><name><surname>Spiropoulou</surname><given-names>FC</given-names></name></person-group> (<year>2016</year>). <article-title>Molecular Insights into Crimean-Congo Hemorrhagic Fever Virus</article-title>. <source>Viruses</source>, <volume>8</volume>(<issue>4</issue>):<fpage>106</fpage>.<pub-id pub-id-type="pmid">27110812</pub-id></mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saghafipour</surname><given-names>A</given-names></name><name><surname>Norouzi</surname><given-names>M</given-names></name><name><surname>Zia Sheikholeslami</surname><given-names>N</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Epidemiologic status of the patients with Crimean Congo Hemorrhagic Fever and its associated risk factors</article-title>. <source>Iran J Military Med</source>,<volume>14</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02013;<lpage>5</lpage>.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamzeh Pour</surname><given-names>S</given-names></name><name><surname>Moradi</surname><given-names>M</given-names></name></person-group> (<year>2017</year>). <article-title>Clinical manifestation and pathophysiology of Crimean-Congo hemorrhagic fever on human</article-title>. <source>J Med Physiol</source>, <volume>2</volume>(<issue>2</issue>):<fpage>32</fpage>&#x02013;<lpage>33</lpage>.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Majidzadeh Ardabili</surname><given-names>K</given-names></name><name><surname>Soleimani</surname><given-names>M</given-names></name><name><surname>Gheilanchi Langrodi</surname><given-names>A</given-names></name></person-group> (<year>2011</year>). <article-title>Review on the Laboratory Diagnosis of Crimean-Congo Hemorrhagic Fever</article-title>. <source>J Army Univ Med Sci</source>, <volume>9</volume>(<issue>4</issue>):<fpage>275</fpage>&#x02013;<lpage>284</lpage>.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drosten</surname><given-names>C</given-names></name><name><surname>K&#x000fc;mmerer</surname><given-names>MB</given-names></name><name><surname>Schmitz</surname><given-names>H</given-names></name><name><surname>G&#x000fc;nther</surname><given-names>S</given-names></name></person-group> (<year>2003</year>). <article-title>Molecular diagnostics of viral hemorrhagic fevers</article-title>. <source>Antiviral Res</source>, <volume>57</volume>(<issue>1&#x02013;2</issue>):<fpage>61</fpage>&#x02013;<lpage>87</lpage>.<pub-id pub-id-type="pmid">12615304</pub-id></mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sargolzaie</surname><given-names>N</given-names></name><name><surname>DehghanHhaghighi</surname><given-names>J</given-names></name><name><surname>Kharazmi</surname><given-names>F</given-names></name></person-group> (<year>2013</year>). <article-title>Crimean Congo Hemorrhagic Fever Surveillance and General Practitioners in Zahedan</article-title>. <source>Medical Journal of Mashhad University of Medical Sciences (MUMS)</source>, <volume>56</volume>(<issue>1</issue>):<fpage>21</fpage>&#x02013;<lpage>25</lpage>[In Persian].</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hassani Azad</surname><given-names>M</given-names></name><name><surname>Abedi</surname><given-names>F</given-names></name><name><surname>Chinikar</surname><given-names>S</given-names></name><name><surname>Bojdy</surname><given-names>A</given-names></name></person-group> (<year>2014</year>). <article-title>Effectiveness of safeguard measures in controlling a nosocomial outbreak of Crimean-Congo hemorrhagic fever</article-title>. <source>Medical Journal of Mashhad University of Medical Sciences (MUMS)</source>, <volume>57</volume>(<issue>4</issue>):<fpage>616</fpage>&#x02013;<lpage>621</lpage>[Persian].</mixed-citation></ref></ref-list></back></article>